SCHEMBL4436697

SCHEMBL4436697

N#Cc1cc2ccccc2nc1-c1ccccc1N

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.61
KDM4E B2RXH2 6/20 0.61
GAA P10253 2/20 0.61
PDE4B Q07343 1/20 0.51
ADORA2A P29274 2/20 0.44
NPC1 O15118 4/20 0.44
RAB9A P51151 4/20 0.44
KMT2A Q03164 4/20 0.44
HPGD P15428 3/20 0.44
GLA P06280 3/20 0.44
LMNA P02545 2/20 0.44
POLB P06746 1/20 0.44
PTBP1 P26599 1/20 0.44
RCE1 Q9Y256 1/20 0.44
MAPT P10636 6/20 0.41
THRB P10828 1/20 0.41
MEN1 O00255 3/20 0.41
TP53 P04637 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
TSHR P16473 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL941858 0.76 ALDH1A1 (1.00) ALDH1A1KDM4EGAANPC1RAB9A
SCHEMBL29904585 0.76 ALDH1A1 (1.00) ALDH1A1KDM4EGAANPC1RAB9A
SCHEMBL10000569 0.74 PDE4B (0.50) ALDH1A1KDM4EGAAPDE4BKMT2A
SCHEMBL6276708 0.73 ADORA2A (0.60) ALDH1A1KDM4EGAAADORA2ANPC1
SCHEMBL7016601 0.73 ALDH1A1 (0.62) ALDH1A1KDM4EGAAPDE4BNPC1
SCHEMBL30804562 0.72 KDM4E (0.53) ALDH1A1KDM4EGAAPDE4BNPC1
SCHEMBL30804559 0.71 TSHR (0.55) ALDH1A1KDM4EGAAADORA2AKMT2A
SCHEMBL30804565 0.71 TSHR (0.55) ALDH1A1KDM4EGAAADORA2AKMT2A
SCHEMBL10028057 0.71 PDE4B (0.56) ALDH1A1KDM4EGAAPDE4BKMT2A
SCHEMBL8026750 0.71 ALDH1A1 (0.65) ALDH1A1KDM4EGAAPDE4BKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1392683-B1 SUBSTITUTED 4H-CHROMENES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS AND THEIR USE AS ANTICANCER AGENTS CYTOVIA INC (US) 2009-12-02 EP disclosed